Molecular docking, DFT and antimicrobial studies of Cu(II) complex as topoisomerase I inhibitor

Autor: Shazia Parveen, Musheer Ahmad, Qian-Fan Zhang, Loïc Toupet, Arif O. Khan, Farukh Arjmand
Přispěvatelé: Aligarh Muslim University, Brown University, Jamia Hamdard, Institut de Physique de Rennes (IPR), Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Centre National de la Recherche Scientifique (CNRS), Université de Rennes (UR)-Centre National de la Recherche Scientifique (CNRS)
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Zdroj: Journal of Biomolecular Structure and Dynamics
Journal of Biomolecular Structure and Dynamics, Taylor & Francis: STM, Behavioural Science and Public Health Titles, 2021, 39 (6), pp.2092-2105. ⟨10.1080/07391102.2020.1743365⟩
Journal of Biomolecular Structure and Dynamics, 2021, 39 (6), pp.2092-2105. ⟨10.1080/07391102.2020.1743365⟩
ISSN: 0739-1102
1538-0254
DOI: 10.1080/07391102.2020.1743365⟩
Popis: Herein, we report the synthesis and single crystal X-ray structure of Cu(II)-picolinic acid complex, 1 as a potent topoisomerase I inhibitor. The complex 1 crystallized in the triclinic crystal system with space group P-1. Comparative in vitro binding studies of complex 1 with CT DNA and tRNA were carried out revealing an electrostatic binding mode with higher binding propensity towards tRNA. The intrinsic bonding constant value, Kb was calculated to be 4.36 × 104 and 8.78 × 104 M−1 with CT DNA and tRNA respectively. DNA cleavage activity was carried out with a pBR322 plasmid DNA substrate to ascertain the cleaving ability. Furthermore, Topo-I inhibition assay of complex 1, performed via gel electrophoresis revealed a significant inhibitory effect on the enzyme catalytic activity at a minimum concentration of 15 µM. The DFT studies were carried out to provide better insight in the electronic transitions observed in the absorption spectrum of the complex 1. Molecular docking studies were carried out with DNA, RNA and Topo-I to determine the specific binding preferences at the target site and complement the spectroscopic studies. The antimicrobial potential of complex 1 was screened against E. coli, S. aureus, P. aeruginosa, B. subtilis and C. albicans; and compared with doxycycline, exhibiting an excellent maximum zone of inhibition of 28 mm against E. coli. Communicated by Ramaswamy H. Sarma
Databáze: OpenAIRE